Dashboard
Manage Tickers

ALLRAllarity Therapeutics, Inc.

Nasdaq allarity.com


$ 0.23 $ 0.01 (6.43 %)    

Monday, 01-Jul-2024 15:59:25 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 481.74 $ 2.81 (0.59 %)
DIA $ 391.56 $ 0.33 (0.08 %)
SPY $ 545.33 $ 1.12 (0.21 %)
TLT $ 90.13 $ -1.58 (-1.73 %)
GLD $ 215.59 $ 0.56 (0.26 %)
$ 0.2266
$ 0.21
$ 0.23 x 1,200
$ 0.23 x 1,200
$ 0.21 - $ 0.23
$ 0.19 - $ 269.80
2,590,232
na
3.99M
$ 1.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-13-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 10-07-2022 06-30-2022 10-Q
9 05-27-2022 03-31-2022 10-Q
10 05-16-2022 09-30-2021 10-Q
11 05-16-2022 12-31-2021 10-K
12 11-23-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

allarity-therapeutics-shares-are-trading-higher-after-the-company-announced-that-it-received-notice-from-the-nasdaq-stock-market-that-it-was-granted-a-hearing
Allarity Therapeutics shares are trading h...
06/27/2024 12:16:30

allarity-granted-hearing-before-nasdaq-panel-to-present-plan-of-regaining-compliance
Allarity Granted Hearing Before Nasdaq Pan...
06/27/2024 12:02:30

Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2 clinical-stage pharmaceutica...

allarity-therapeutics-dual-parptankyrase-inhibitor-stenoparib-to-show-extended-clinical-benefit-in-advanced-ovarian-cancer
Allarity Therapeutics' Dual PARP/Tankyrase...
06/25/2024 12:09:37

Multiple patients have now exceeded 30 weeks on treatment Boston (June 25, 2024)—Allarity Therapeutics, Inc. ("Allarity"...

why-allarity-therapeutics-allr-stock-is-getting-hammered
Why Allarity Therapeutics (ALLR) Stock Is ...
06/24/2024 20:28:26

Allarity Therapeutics shares are trading lower by 27.6% during Monday's session. The company announced that it received a n...

dow-jumps-300-points-alimera-sciences-shares-spike-higher
Dow Jumps 300 Points; Alimera Sciences Sha...
06/24/2024 17:06:48

reported-earlier-allarity-therapeutics-faces-nasdaq-delisting-for-stock-price-below-1
Reported Earlier, Allarity Therapeutics Fa...
06/24/2024 11:49:34

On June 18, 2024, Allarity Therapeutics, Inc. (the “Company”) received a letter from the Nasdaq Listing Qualifications Staff (t...

allarity-therapeutics-regains-nasdaq-compliance
Allarity Therapeutics Regains Nasdaq Compl...
05/20/2024 12:07:43

allarity-therapeutics-reports-clear-clinical-benefits-from-phase-2-trial-improves-cash-balance-of-14m-and-equity-balances-of-15m-withdraws-from-s-1
Allarity Therapeutics Reports Clear Clinic...
05/14/2024 20:09:25

- Phase 2 Trial of Stenoparib Concluded Early due to Clear Clinical Benefits Achieved- On Track to Regain Compliance with All N...

allarity-therapeutics-q1-eps-2214
Allarity Therapeutics Q1 EPS $(22.14)
05/14/2024 20:06:16

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/07/2024 16:31:17

allarity-therapeutics-announces-that-all-series-a-preferred-and-all-variable-priced-warrants-have-converted-to-common-stock-convertible-at-20share
Allarity Therapeutics Announces that All S...
05/07/2024 13:33:47

allarity-therapeutics-shares-are-trading-higher-after-the-company-announced-that-its-stockholders-equity-is-significantly-above-the-25-million-minimum-required-by-nasdaq-listing-rule-and-will-submit-a-request-to-the-sec-to-withdraw-form-s-1
Allarity Therapeutics shares are trading h...
05/06/2024 12:50:14

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/06/2024 12:06:38

allarity-therapeutics-exceeds-nasdaqs-minimum-equity-requirement-requests-voluntarily-withdrawal-of-form-s-1
Allarity Therapeutics Exceeds Nasdaq's Min...
05/06/2024 12:02:11

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/03/2024 16:31:47

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 20:31:10

why-is-nano-cap-allarity-therapeutics-stock-trading-up-on-thursday
Why Is Nano-Cap Allarity Therapeutics Stoc...
05/02/2024 16:29:08

Allarity Therapeutics halts Phase 2 trial, citing compelling early results and plans for regulatory advancement. CEO Thomas Jen...

nasdaq-jumps-over-100-points-kellanova-posts-upbeat-results
Nasdaq Jumps Over 100 Points; Kellanova Po...
05/02/2024 13:52:05

Core News & Articles
Market-Moving News May 2nd
05/02/2024 12:39:37

ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 12:06:54

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)